Marina Pajic is a leader in pancreatic cancer research. Since returning from the Netherlands and establishing her lab at the Garvan in 2013, Associate Professor Marina Pajic has developed an innovative program that builds on the unique infrastructure she has generated, a wealth of integrated human cancer genomic and gene product expression profiles, complex 3D and patient-derived mouse models, rapidly evolving technologies, and close clinical links, to reveal new insights into the deregulation of molecules commonly hijacked in pancreatic cancer, which drive tumour (i) heterogeneity (ii) metastasis and (iii) chemoresistance. She has built a large integrated program with Australian and International collaborators and is using this knowledge to inform the rational design of novel, tailored treatment options for pancreatic cancer.
Her research is supported by the NHMRC, Cancer Australia, Cancer Council NSW, Tour de Cure, ACRF, CINSW, the Philip Hemstritch Fellowship in Pancreatic Cancer and the Girgensohn Foundation. Marina’s contributions have been recognised by several prestigious awards including the Australian Academy of Science 2020 Ruth Stephens Gani Medal for achievements in the field of applied cancer genomics and precision medicine for pancreatic cancer, the NSW Premier’s Outstanding Cancer Research Fellow Award and the Cancer Institute NSW Wildfire and Rising Star Awards.